SCHEMBL9728943

SCHEMBL9728943

CC(=O)CC(=O)c1ccccc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ KDM4E B2RXH2 4/20 0.50
▸ HMGB1 P09429 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ NAPRT Q6XQN6 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ ESR1 P03372 1/20 0.50
▸ ITGB3 P05106 1/20 0.50
▸ ITGA2B P08514 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ GGT1 P19440 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ USP2 O75604 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ ERCC5 P28715 1/20 0.47
▸ FEN1 P39748 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11950516 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15KDM4EHMGB1HPGD
Phthalic Acid SCHEMBL28536019 0.85 ALDH1A1 (0.61) ALDH1A1ALOX15KDM4EHMGB1HPGD
SCHEMBL14980978 0.82 AKR1C3 (0.57) ALDH1A1ALOX15KDM4EHPGDTDP1
SCHEMBL27467792 0.81 G6PD (0.52) ALDH1A1ALOX15KDM4EHMGB1HPGD
Phthalic Acid SCHEMBL3030281 0.80 ALDH1A1 (0.67) ALDH1A1ALOX15KDM4EHMGB1HPGD
SCHEMBL11170734 0.80 ALDH1A1 (0.57) ALDH1A1ALOX15KDM4EHSD17B10TSHR
Phthalic Acid SCHEMBL2561870 0.79 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHMGB1HPGD
Phthalic Acid SCHEMBL8398555 0.79 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHMGB1HPGD
Phthalic Acid SCHEMBL7897915 0.79 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHMGB1HPGD
Phthalic Acid SCHEMBL30100313 0.79 ALDH1A1 (0.82) ALDH1A1ALOX15KDM4EHMGB1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5149688-A Administering effective amounts of methotrexate and succinylacetone, a seven carbon ketoacid; for rheumatoid arthritis; autoimmune diseases CETUS CORPORATION (US) 1992-09-22 — — US disclosed
WO-1991016046-A1 USE OF ACETOACETYL CARBOXYLIC ACID DERIVATIVES FOR IMMUNOSUPPRESSION CETUS CORPORATION (US) 1991-10-31 — — WO disclosed
Send feedback